DBV Technologies S.A. (DBVT) Financial Ratios
15 years of historical data (2011–2025) · Healthcare · Biotechnology
EV/EBITDA
N/A
—
5yr avg: N/A
P/FCF
N/A
—
5yr avg: N/A
P/B Ratio
↓
0.64
↓-55% vs avg
5yr avg: 1.42
30Y Low0.6·High3.3
ROE
↓
-150.3%
↑-64% vs avg
5yr avg: -91.9%
30Y Low-150%·High-17%
Debt/EBITDA
N/A
—
5yr avg: N/A
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
DBVT Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
DBV Technologies S.A. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $1669.52T | $107M | $59M | $182M | $237M | $176M | $283M | $396M | $186M | $609M | $859M |
| Enterprise Value | $1669.52T | $-65457465 | $35M | $47M | $32M | $110M | $103M | $230M | $23M | $421M | $581M |
| P/E Ratio → | -0.74 | — | — | — | — | — | — | — | — | — | — |
| P/S Ratio | — | — | — | 11.55 | 49.33 | 30.89 | 25.14 | 26.92 | 14.49 | 52.87 | 108.38 |
| P/B Ratio | 0.64 | 0.63 | 2.17 | 1.30 | 1.22 | 1.78 | 1.38 | 2.05 | 1.12 | 3.33 | 3.21 |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
DBVT EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | — | — | 2.98 | 6.62 | 19.21 | 9.10 | 15.63 | 1.80 | 36.58 | 73.35 |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — | — | — | — |
DBVT Profitability
Margins and return-on-capital ratios measuring operating efficiency
A negative ROE of -150.3% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | — | — | — | 100.0% | -322.9% | -62.5% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating Margin | — | — | — | -486.0% | -2013.1% | -1727.6% | -1408.7% | -1162.8% | -1483.6% | -1510.0% | -1540.6% |
| Net Profit Margin | — | — | — | -462.4% | -2006.3% | -1713.5% | -1415.0% | -1169.5% | -1484.7% | -1538.3% | -1593.9% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -150.3% | -150.3% | -135.7% | -43.5% | -65.6% | -64.2% | -80.0% | -95.8% | -109.1% | -78.6% | -38.7% |
| ROA | -98.5% | -98.5% | -91.5% | -33.9% | -49.0% | -46.7% | -58.7% | -67.9% | -78.5% | -62.5% | -34.8% |
| ROIC | — | — | -2231.7% | -1067.1% | -664.9% | -259.5% | -461.0% | -847.2% | -4441.0% | — | — |
| ROCE | -145.7% | -145.7% | -133.8% | -42.2% | -58.2% | -59.0% | -72.7% | -87.0% | -101.4% | -71.7% | -36.2% |
DBVT Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
The company holds a net cash position — cash of $194M exceeds total debt of $22M, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.13 | 0.13 | 0.28 | 0.05 | 0.02 | 0.11 | 0.08 | 0.14 | 0.03 | 0.04 | 0.02 |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | -1.02 | -0.90 | -0.96 | -1.05 | -0.67 | -0.88 | -0.86 | -0.98 | -1.03 | -1.04 |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — | — | — | — | — | — |
| Interest Coverage | — | — | — | — | -227.12 | -144.25 | -186.87 | -452.53 | -396.92 | -43.46 | -6897.62 |
Net cash position: cash ($194M) exceeds total debt ($22M)
DBVT Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
DBV Technologies S.A.'s current ratio of 3.67x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The current ratio has declined from 4.26x to 3.67x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.67 | 3.67 | 1.43 | 4.26 | 7.56 | 3.65 | 3.93 | 3.79 | 3.34 | 4.37 | 9.38 |
| Quick Ratio | 3.67 | 3.67 | 1.43 | 4.26 | 7.47 | 3.65 | 3.93 | 3.75 | 3.30 | 4.31 | 9.38 |
| Cash Ratio | 3.35 | 3.35 | 1.04 | 3.79 | 7.09 | 2.46 | 3.72 | 3.58 | 2.82 | 3.84 | 8.84 |
| Asset Turnover | — | — | — | 0.09 | 0.02 | 0.04 | 0.04 | 0.05 | 0.05 | 0.05 | 0.02 |
| Inventory Turnover | — | — | — | — | 7.57 | — | — | — | 2.35 | 1.19 | — |
| Days Sales Outstanding | — | — | — | 358.43 | 798.00 | 2114.42 | 254.43 | 134.23 | 574.04 | 629.47 | 626.87 |
DBVT Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
DBV Technologies S.A. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.1% | 0.1% | 0.0% | 0.0% | 0.2% | 0.0% | 0.3% | 0.0% | 0.0% |
| Total Shareholder Yield | 0.0% | 0.0% | 0.1% | 0.1% | 0.0% | 0.0% | 0.2% | 0.0% | 0.3% | 0.0% | 0.0% |
| Shares Outstanding | — | $6M | $19M | $19M | $15M | $11M | $11M | $7M | $6M | $5M | $5M |
Peer Comparison
Compare DBVT with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 DBVTYou | $1669.5T | -0.7 | — | — | — | — | -150.3% | — | — |
 ALKS | $6B | 25.3 | 18.0 | 12.7 | 86.3% | 17.2% | 14.7% | 18.9% | 0.2 |
 PRGO | $2B | -1.1 | — | 11.0 | 35.1% | -26.4% | -39.3% | -17.1% | — |
 SLRX | $697790 | -0.0 | — | — | — | — | -164.0% | — | — |
 SNGX | $3M | -0.1 | — | — | — | — | -249.0% | — | — |
 HALO | $8B | 25.7 | 8.4 | 12.0 | 78.1% | 58.4% | 153.6% | 73.4% | — |
 ALK | $4B | 44.3 | 9.7 | — | 59.7% | 2.1% | 2.4% | 2.3% | 6.3 |
 REGN | $73B | 16.9 | 17.6 | 17.9 | 85.4% | 24.9% | 14.9% | 8.9% | 0.7 |
 SANA | $915M | -3.0 | — | — | — | — | -99.2% | -86.1% | — |
 IMVT | $6B | -10.2 | — | — | — | — | -62.5% | — | — |
 CABA | $424M | -2.5 | — | — | — | — | -127.0% | -429.6% | — |
| Healthcare Median | — | 22.2 | 14.0 | 18.6 | 64.1% | -5.3% | -34.0% | -11.2% | 3.1 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 15 years · Updated daily
Full DBVT Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
Should I Buy DBVT Right Now?
Bull case, key risks, Wall St analyst verdict, and what council investors are saying — updated daily.
See DBVT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs DBVT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare DBVT vs ALKS
Side-by-side business, growth, and profitability comparison vs Alkermes plc.
Start ComparisonDBVT — Frequently Asked Questions
Quick answers to the most common questions about buying DBVT stock.
What is DBV Technologies S.A.'s P/E ratio?
DBV Technologies S.A.'s current P/E ratio is -0.7x. This places it at the 50th percentile of its historical range.
What is DBV Technologies S.A.'s ROE?
DBV Technologies S.A.'s return on equity (ROE) is -150.3%. The historical average is -68.4%.
Is DBVT stock overvalued?
Based on historical data, DBV Technologies S.A. is trading at a P/E of -0.7x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.